جست‌وجوی استاد و پژوهشگر

Karin Ortmayrمشاهده پروفایل

استادیار

• Phytochemistry
• Biodiscovery
• Metabolomics
• +۴ مورد دیگر

Karin Ortmayr serves as an Assistant Professor at the University of Vienna within the Faculty of Life Sciences, Department of Pharmaceutical Sciences, specifically in the Division of Pharmacognosy. Her research laboratory is located in room 2G 154 (floor 1) at Josef-Holaubek-Platz 2, A-1090 Vienna, Austria. Her primary research interests focus on Phytochemistry & Biodiscovery , Molecular Targets , and MS-based metabolome profiling . Dr. Ortmayr investigates the impact of cellular plasticity on cellular metabolism and responses to stress & bioactive compounds. Her work addresses fundamental questions on the interplay between different cell states, cellular metabolism, and the action of bioactive compounds, with particular emphasis on (1) harnessing cell state-specific vulnerabilities to target disease-relevant cell subpopulations like quiescent cancer cells (cancer recurrence), and (2) considering cell state switches to improve cell-based systems for drug discovery. Her research employs advanced analytical tools in mass spectrometry-based metabolomics for systematic studies in human health and disease. She utilizes combined metabolic- and phenotypic profiling approaches, with technologies including mass spectrometry-based metabolomics (non-targeted and targeted), in vitro cell cultivation and multiparallel perturbation studies (96-well format), live-cell microscopy imaging, and integrative computational data analysis. Her publication record demonstrates consistent research output from 2014 through 2025, with a recent focus on metabolic mapping of pharmacological perturbations, biopharmaceutical profiling of natural compounds, and the relationship between cellular plasticity and metabolism in disease contexts. Her work spans microbiology, cancer research, metabolomics, and phytochemistry, reflecting interdisciplinary approaches to understanding metabolic pathways and their therapeutic applications. Dr. Ortmayr utilizes mass spectrometry-based metabolomics as her primary analytical approach, with applications ranging from antibacterial compound discovery to cancer cell metabolism and natural product analysis. Her research bridges fundamental metabolic understanding with practical applications in drug discovery and disease treatment. Her laboratory work involves in vitro cell cultivation, high-throughput perturbation studies, live-cell imaging, and computational data analysis to investigate metabolic responses to various stressors and bioactive compounds. This integrated approach allows for comprehensive analysis of cellular metabolic states and their implications for disease mechanisms and therapeutic interventions.

Agata A. Exnerمشاهده پروفایل

استاد

• Image-guided drug delivery
• Ultrasound contrast agents
• Interventional Oncology
• +۳ مورد دیگر

Agata A. Exner is the Henry Willson Payne Professor in the Department of Radiology at Case Western Reserve University School of Medicine and a Professor in the Department of Biomedical Engineering at the Case School of Engineering . She serves as Vice Chair of Basic Research , Director of the CWRU Center for Imaging Research , and Co-Leader of the Cancer Imaging Program at the Case Comprehensive Cancer Center . Education: PhD in Biomedical Engineering, Case Western Reserve University (2003) BS in Biomedical Engineering, Case Western Reserve University (1998) Research Focus spans image-guided drug delivery , ultrasound contrast agents , interventional oncology , nanomedicine , and cancer detection/therapy . Her work integrates ultrasound imaging with nanotechnology to develop theranostic systems for tumor targeting . Article Trends emphasize ultrasound-mediated drug delivery , nanocontrast agents , and real-time imaging for cancer therapy monitoring . Key methodologies include microfluidic models , high-throughput ultrasound techniques , and in situ forming implants . Scientific Awards Elected Senior Member, National Academy of Inventors (2024) Mather Spotlight Woman of Achievement Award (2015) Distinguished Investigator Award, The Academy for Radiology and Biomedical Imaging Research (2013) Fellow, American Institute for Medical and Biological Engineering (2015) Labs & Teams : She leads the CWRU Center for Imaging Research and contributes to the Medical Scientist Training Program at CWRU School of Medicine.

Jennifer Glennمشاهده پروفایل

دانشیار

• Applied statistics and process improvement
• Economic analysis
• Service systems and processes
• +۵ مورد دیگر

Dr. Jennifer Glenn serves as an Associate Professor in the Industrial Engineering & Management department at Oklahoma State University's College of Engineering, Architecture and Technology (CEAT). Her work bridges engineering principles with biological systems through research on statistical process improvement and service systems. PhD in Industrial Systems Engineering (Georgia Tech, 1996) MS in Statistics (Georgia Tech, 1993) MS in Industrial Engineering (Oklahoma State, 1991) BS in Industrial Engineering (Oklahoma State, 1990) Research focuses on applied statistics for quality control and process optimization, economic analysis of engineering systems, service process modeling , and pedagogical innovations in engineering education. Since 2013, she has advised the Society of Women Engineers at OSU, receiving multiple teaching and advising awards including the 2024 OSU Regents Distinguished Teaching Award. Recent collaborative publications explore gut microbiome dynamics in poultry and livestock, host defense peptide modulation through diet, and microbial interventions for metabolic and inflammatory disorders. Her work spans interdisciplinary applications of engineering principles to biological systems. Scientific Awards: IEM Faculty Impact Award (2025) OSU Regents Distinguished Teaching Award (2024) CEAT Outstanding Senior Faculty Teaching Award (2023) Outstanding Student Organization Advisor of the Year (2018) Excellent Young Teacher Award (2015) Diversity Faculty of the Year Award (2012)

Hugo Fernandesمشاهده پروفایل

پژوهشگر ارشد

• Neurodegeneration
• Parkinson's Disease
• Alzheimer's Disease
• +۵ مورد دیگر

Hugo Fernandes is a Junior Research Fellow and Group Leader in the Department of Physiology, Anatomy and Genetics at the University of Oxford. He leads a research group focused on understanding early neuronal dysfunction in Parkinson’s and Alzheimer’s diseases, utilizing patient-derived stem cell models to explore lipid dysfunction as a disease mechanism. His work aims to identify novel therapeutic targets to improve patient outcomes. Fernandes holds a DPhil in Neurodegeneration from the University of Oxford (2014) and is affiliated with the Kavli Institute for Nanoscience Discovery. His research interests emphasize stem cell-based disease modeling, lipid metabolism in neurodegeneration, and the application of advanced omics technologies. Key focuses include proteostasis disruptions, mitochondrial dysfunction, and the interplay between genetic mutations (e.g., GBA1, MAPT) and cellular stress pathways. Recent publications highlight his team’s exploration of CRISPR-based genetic screens, single-cell omics, and neuroprotective interventions. Their studies reveal novel insights into lipid dysregulation, ER stress, and therapeutic candidates like KAT2B inhibitors. While no formal students are listed, his group actively contributes to collaborative projects in neurodegenerative disease research. Fernandes’ work integrates molecular, cellular, and systems-level approaches to bridge basic science and clinical translation, with a focus on developing precision medicine strategies for Parkinson’s disease.

Jeffrey Bluestoneمشاهده پروفایل

استاد

• Immunology
• Autoimmune Diseases
• Organ Transplantation
• +۴ مورد دیگر

Jeffrey Bluestone is the A.W. and Mary Margaret Clausen Distinguished Professor of Metabolism and Endocrinology and Director of the Hormone Research Institute in the Diabetes Center at the University of California San Francisco (UCSF) School of Medicine. He has served as Executive Vice Chancellor and Provost (2010-2016) and Interim Vice Chancellor of Research (2008), guiding UCSF's academic enterprise and research strategy while securing top-tier federal funding including American Recovery and Reinvestment Act allocations. His educational foundation includes: B.S. in Biology from Rutgers University (1974) M.S. in Microbiology from Rutgers University (1977) Ph.D. in Immunology from Cornell Graduate School of Medical Science (1980) Bluestone's research pioneers immune tolerance mechanisms with emphasis on regulatory T cells (Tregs) in autoimmunity and transplantation. His lab developed foundational tools including soluble receptor antagonists and TCR-deficient models to define co-stimulatory pathways, establishing antigen-specific Tregs as superior therapeutic agents. Current work focuses on Treg stability engineering, pharmacogenomic modulation, and translating animal studies into human therapies for Type 1 Diabetes and transplant rejection through biologics and cell-based treatments. His 2024-2025 publications reveal critical trends: engineering next-generation Treg therapies (CAR-Tregs, orthogonal IL-2 systems), elucidating pancreatic autoimmunity mechanisms, optimizing cell manufacturing, and addressing immune checkpoint inhibitor toxicities. Key themes include antigen-specific targeting, molecular engineering of immunomodulators, and clinical translation of tolerance-inducing strategies across autoimmune diseases and transplantation. Major scientific accolades include: Election to National Academy of Medicine (2015) and American Academy of Arts and Sciences (2008) Roche Distinguished Research Award (2005) and Mary Tyler Moore Clinical Research Award (2006) Outstanding Mentorship Award from American Society of Transplantation (2015) Gerold & Kayla Grodsky Basic Science Award (2004) Elliott Middleton Memorial Lectureship (2013) As principal investigator, Bluestone founded and directed the Immune Tolerance Network (1,000+ researchers across 50 institutions) testing novel tolerance therapies, and secured $500M+ in stimulus funds for UCSF research. His lab has trained generations of immunologists while advancing Treg-based therapeutics through IND-enabling studies and clinical trials. Current initiatives include engineering antigen-specific CAR-Tregs for rheumatoid arthritis and optimizing Treg expansion protocols for clinical use. Bluestone leads the Hormone Research Institute within UCSF's Diabetes Center, coordinating multidisciplinary teams spanning basic immunology, translational science, and clinical trials. His laboratory collaborates with the Immune Tolerance Network and industry partners to accelerate development of tolerance-inducing therapies, with ongoing projects focused on TCR identification for antigen-specific Tregs and pharmacogenomic stabilization strategies for autoimmune and cancer applications.

Damian Youngمشاهده پروفایل

استادیار

• Synthetic organic chemistry
• Fragment-based drug discovery
• Diversity-oriented synthesis
• +۲ مورد دیگر

Dr. Damian Young is an Assistant Professor at Baylor College of Medicine, holding dual appointments in the Department of Pharmacology and Chemical Biology and the Department of Pathology. He also serves as an Adjunct Assistant Professor at Rice University's Chemistry Department and is a member of the Dan L Duncan Comprehensive Cancer Center. His research focuses on synthetic organic chemistry, fragment-based drug discovery, and chemical biology, particularly targeting cancer therapies. Dr. Young earned a BS from Howard University, a PhD from North Carolina State University, and completed a postdoctoral fellowship at Harvard University and the Broad Institute. He has received notable awards, including the CPRIT Scholar award (2014) and NIH Minority Predoctoral Fellowship (2000-2004). His research emphasizes developing chemical pathways for small-molecule probes and fragment-based drug discovery against challenging targets. Key projects include the Recruitment of First-Time Tenure Track Faculty Members (CPRIT-funded, $2M) and SPARC Program grants. The Young Lab collaborates with institutions like the Broad Institute and focuses on methodologies such as diversity-oriented synthesis and macrocyclic compound design. Grants: Recruitment Award ($2M, CPRIT, 2014-2018) Broad Institute SPARC Program ($100K, 2011-2012) NIH P50 Center ($1.25M portion, 2008-2013) Lab activities include exploring synthetic strategies for drug discovery, such as the build/couple/pair approach for macrocyclic inhibitors and stereodivergent synthesis of hybrid fragments. The lab is affiliated with Baylor's Center for Drug Discovery and collaborates on projects like GSK3β inhibitor development.

Rupert Bealeمشاهده پروفایل

استاد پژوهشی

• Immunology
• Infectious Disease
• Virology
• +۳ مورد دیگر

Rupert Beale is a Research Professor and Group Leader at The Francis Crick Institute in London, UK. He previously held roles as a Clinical Lecturer in Nephrology and Immunology at the University of Cambridge (2013–2015) and an MRC Clinician Scientist Fellow (2015–2019). His research focuses on viral interactions with host cells, particularly influenza and SARS-CoV-2, with a focus on autophagy pathways and immune responses. Education: MB/PhD from the University of Cambridge/MRC Laboratory of Molecular Biology (2005) MRCP qualification (2007) Research Interests: His work explores how viruses exploit cellular machinery like autophagy, with studies on LC3 lipidation pathways, viral protein interactions, and immune evasion strategies. He also investigates SARS-CoV-2 variants, vaccine efficacy, and antibody responses in immunocompromised populations. Key Contributions: Discovered influenza's direct interaction with autophagy machinery Developed high-throughput testing strategies for SARS-CoV-2 Explored neutralizing antibody dynamics in Omicron and Delta variants Awards: MRC Clinician Scientist Fellowship (2015–2019) Labs/Teams: His group at the Crick collaborates with institutions like the Royal Free Hospital and the Worldwide Influenza Centre, focusing on virology, autophagy, and infectious disease.

• Condensed Matter Physics
• Computational Materials Science
• Artificial Intelligence in Materials Discovery
• +۱۱ مورد دیگر

Aldo H. Romero is the Eberly Family Distinguished Professor of Physics and Astronomy at West Virginia University, where he serves as Director of Research Computing . His research integrates computational materials science, artificial intelligence, and high-performance computing to advance understanding of condensed matter systems, including strongly correlated materials, 2D materials, and magnetic compounds. Education : Ph.D. in Physics and Chemistry from University of California, San Diego (1998) Awards : Eberly Family Distinguished Professorship Romero’s group specializes in Density Functional Theory (DFT) , Dynamical Mean Field Theory (DMFT) , and machine learning for materials discovery. They develop open-source tools like PyProcar , MechElastic , and ABINIT , focusing on properties such as electronic structure, elastic behavior, and magnetic interactions. Recent work explores chiral materials , AI-driven optimization , and high-throughput computational methods for material design. Key trends in publications include studies on chiral symmetry in kagome lattices, machine learning for material properties, symmetry-based structure prediction, and DFT+DMFT analysis of correlated systems. Collaborations span Germany, France, China, Spain, and Italy, with applications in energy storage, quantum technologies, and spintronics. Scientific contributions encompass: Development of Fireball and ABINIT codes Machine learning for Hubbard U parameter optimization Chiral material discovery via symmetry arguments Pioneering work on 2D Rashba systems Labs and teams include: AI WVU Discussion Group (founded by Romero) West Virginia University Computational Materials Group Collaborative efforts with international institutions Grants and proposals highlight initiatives like the NSF & NVIDIA Open Multimodal AI Infrastructure (OMAI) program and Spencer Foundation support for AI in education. The group works with over 20 graduate students and 4 postdoctoral researchers, emphasizing interdisciplinary training and global collaboration.

Abigail N. Koppesمشاهده پروفایل

دانشیار

• Bioelectric Medicine
• Neural Engineering
• Biomaterials
• +۷ مورد دیگر

Abigail N. Koppes is an Associate Professor of Chemical Engineering at Northeastern University, with affiliations in Bioengineering and the Cross-College Magnetics Center. Her Advanced Biomaterials for NeuroEngineering Laboratory (ABNEL) focuses on bioelectric medicine, nerve regeneration, and organ-on-a-chip systems for gut-brain axis modeling. She holds a B.S., M.S., and Ph.D. in Biomedical Engineering from Rensselaer Polytechnic Institute (2007-2013). Research interests include developing biomaterials and biophysical interventions (e.g., optogenetics, magnetic stimulation) to engineer neural therapies and recapitulate complex biological systems like the enteric nervous system. Notable projects involve neural-guided repair of spinal injuries, gut-on-a-chip platforms for drug discovery, and chronic inflammation modeling. Koppes has secured NIH Trailblazer and NSF CAREER awards, alongside the Rita Schaffer Young Investigator recognition. Her lab integrates techniques from chemical engineering, materials science, and molecular biology to address disorders such as irritable bowel diseases and neurodegenerative conditions. She mentors PhD students (e.g., Bryan Schellberg, Kyla Kaiser) and leads interdisciplinary grants, including NASA-funded neurovascular systems. Recent work includes modeling Sjögren’s syndrome gut-brain axis dysfunction and exploring long-COVID impacts through organ-chip platforms. Koppes collaborates on PEAK undergraduate research programs and has been featured in media for her contributions to bioelectric medicine and personal insights on long-COVID challenges in academia. The ABNEL lab’s innovations span neural engineering, gut-organoid systems, and magnetic stimulation therapies.

Gretchen Mahlerمشاهده پروفایل

استاد

• Organ-on-a-Chip Technology
• Tissue Engineering
• Nanotoxicology
• +۳ مورد دیگر

Gretchen Mahler is Professor of Biomedical Engineering at Binghamton University and Interim Vice Provost and Dean of The Graduate School. She holds a BS from the University of Massachusetts Amherst and PhD from Cornell University. Her laboratory develops microfluidic and 3D scaffold systems to create physiologically realistic models of organs and tissues, with applications in cardiovascular disease, cancer, and gastrointestinal health. Dr. Mahler's research integrates microfluidics, tissue engineering, and computational modeling to study disease mechanisms and nanoparticle interactions. Her work focuses on endothelial-to-mesenchymal transformation, nanoparticle toxicity in gastrointestinal systems, and kidney-on-a-chip technologies that replicate human renal function for drug testing. Recent publications demonstrate strong emphasis on organ-mimetic systems, with 67% focusing on microphysiological platforms and 33% on nanomaterial-biological interactions. Article keywords predominantly include Microfluidics (87%), Disease Modeling (73%), Nanoparticles (60%), and Tissue Engineering (53%). Awards and Honors: Provost's Award for Outstanding Graduate Director (2017) Lush Prize (2015) Dr. Nuala McGann Drescher Award (2015) The Hartwell Foundation Postdoctoral Fellowship (2008) Dr. Mahler advises 9 graduate students and postdoctoral researchers. Her lab has secured multiple NIH grants for developing organ-on-chip platforms and studying nanomaterial biosafety. Current projects include creating multi-organ systems and investigating nanoparticle effects on nutrient absorption. The Mahler Lab maintains active collaborations with pharmaceutical companies and clinical researchers to translate microphysiological models into drug development pipelines. Future work explores integration of immune components into tissue chips and patient-derived cell models.

Oliver Billkerمشاهده پروفایل

استاد

• Malaria Research
• Parasitology
• Molecular Biology
• +۵ مورد دیگر

Oliver Billker is a Professor at the Department of Molecular Biology, Umeå University, and serves as Manager of the Molecular Infection Medicine Sweden (MIMS) research group. His research focuses on understanding the biology of malaria parasites and their interactions with mosquitoes, particularly investigating genetic mechanisms and transmission pathways. His work combines cutting-edge genomic tools, CRISPR screening, and single-cell technologies to uncover new insights into parasite development and host-pathogen interactions. Research interests include malaria parasite genetics, drug resistance mechanisms, mosquito vector biology, and the application of genomic approaches to identify novel drug and vaccine targets. Key achievements include the discovery of essential genes for transmission and the development of high-throughput genetic screening platforms for Plasmodium species. Notable awards include the Hirsch Prize and election as EMBO Member. His lab, the Oliver Billker Lab, collaborates internationally to advance malaria research. Recent grants include multi-million SEK investments for basic research at Umeå University and contributions to global initiatives like the Malaria Cell Atlas. Awards: Hirsch Prize EMBO Membership Grants/Projects: VR funding for basic research (2024) Nordic collaboration grants Malaria Cell Atlas initiative Labs/Teams: Oliver Billker Lab Molecular Infection Medicine Sweden (MIMS) His research bridges fundamental biology and translational medicine, aiming to combat malaria through innovative approaches in genomics and systems biology.

• Microfluidics
• Point-of-Care Diagnostics
• Cell Analysis
• +۲ مورد دیگر

Aman Russom is a Professor in Clinical Microfluidics at KTH Royal Institute of Technology. His research group develops microfluidic technologies for point-of-care diagnostics, focusing on cell handling, analysis, and separation techniques for biomedical applications. The group works at the intersection of nanotechnology, fluid dynamics, and biomedical engineering to create advanced lab-on-chip systems. Research interests center on developing miniature laboratories for complex biochemical analyses, particularly for blood samples. Key areas include: Automated cell picking and separation techniques Elasto-inertial focusing of nanoparticles Acoustofluidic methods for environmental monitoring Diagnostic platforms for resource-limited settings Recent publications show strong trends in diagnostic microdevice development, with innovations in fiber-based systems, smartphone-integrated platforms, and multiplexed detection methods. Work consistently addresses clinical translation challenges through surface engineering, 3D tracking, and signal enhancement strategies. The group maintains active collaborations with clinical partners and focuses on creating real-world solutions for healthcare and environmental monitoring.

David Mota-Sanchezمشاهده پروفایل

دانشیار

• Insecticide Resistance
• Biotechnology
• Insect Physiology
• +۶ مورد دیگر

Dr. David Mota-Sanchez is an **Associate Professor of Insect Toxicology** in the **Department of Entomology** at **Michigan State University (MSU)**, part of the **College of Agriculture & Natural Resources**. His research focuses on **arthropod resistance to pesticides**, **insecticide toxicology**, and **integrated pest management (IPM)**. He co-directs the **Arthropod Pesticide Resistance Database**, a globally recognized tool tracking pesticide resistance since 1914. His work spans **fall armyworm**, **Colorado potato beetle**, and **western flower thrips** resistance, with projects in the U.S., Mexico, and Latin America. He also leads **La Cosecha**, an extension program supporting Latino farmers in accessing USDA programs and grants, impacting over 200 farms and securing $3M in funding. **Education & Experience**: Ph.D. in Entomology from MSU. Professional roles include Assistant Professor (MSU, 2009–present), Visiting Research Associate (MSU, 2003–2009), and roles in Mexico’s agricultural sector (1988–2002). Notable collaborations include work with Ecuador’s INIAP on pesticide impacts and a **Monarch butterfly conservation project** in Michigan and Mexico. **Research Focus**: Combines lab techniques (e.g., radiotracer studies) with fieldwork to understand resistance mechanisms. Recent projects address **Bt toxin adaptation**, **transgenerational pesticide effects**, and **RNAi-based pest control**. His database is widely used by agencies like the EPA, USDA, FAO, and WHO. **Grants & Impact**: Secured USDA grants (e.g., $600K for La Cosecha) and published over 100 peer-reviewed articles. His work highlights **sustainable pest management**, emphasizing resistance management through diversified tactics like refuge crops and pheromone use. **Labs & Teams**: Leads the **Arthropod Pesticide Resistance Database team** and collaborates globally on projects like Myanmar’s fall armyworm control. His lab hosts visiting scientists from Turkey, China, Mexico, and Ecuador for training in xenobiotic adaptation research.

Evelyn Yimمشاهده پروفایل

استاد

• Biomaterials
• Tissue Engineering
• Nanopatterning
• +۳ مورد دیگر

Evelyn Yim is a Professor and Canada Research Chair in Nanomaterials for Regenerative Medicine (Tier 1) at the University of Waterloo. Her research focuses on biomaterials, tissue engineering, and nanotopography to regulate stem cell behavior. Her work spans applications in corneal regeneration, vascular graft engineering, and neural differentiation. Her research interests include the development of biomaterial-based strategies for corneal endothelial cell expansion, functional wound dressings, and enzyme-responsive hydrogels. She also investigates the effects of surface topography on vascular and neuronal cells, aiming to create bio-inspired materials that mimic natural environments. Key contributions include advancements in biomaterials for vascular compliance matching, droplet microfluidics for cell encapsulation, and enzyme-triggered drug delivery systems. Her work bridges material science and clinical applications, with a focus on translational regenerative medicine. Dr. Yim’s research has produced over 50 peer-reviewed articles since 2020, addressing topics from nanotopography-driven stem cell differentiation to hemocompatible vascular grafts. Her lab (YimLab) is a leader in biomaterials innovation for medical applications.

Marc H Gershowمشاهده پروفایل

دانشیار

• Neuroscience
• Neurophysiology
• Sensory Systems
• +۳ مورد دیگر

Marc H Gershow is an Associate Professor and Director of Undergraduate Studies for Physics at New York University's College of Arts and Science. His research focuses on understanding sensory processing and decision-making in model organisms like Drosophila larvae and C. elegans. He develops advanced microscopy techniques, including CRASH2p and 3D tracking two-photon imaging, to study neural activity in freely behaving animals. His work bridges neuroscience, physics, and engineering to uncover how organisms integrate sensory information with learned and innate behaviors. Education & Background While specific educational details are not explicitly listed, his research trajectory suggests a strong background in biophysics and neuroscience. His lab homepage indicates ongoing projects in olfactory circuits, sensory integration, and neurophysiological imaging. Research Interests Gershow's lab investigates neural mechanisms underlying navigation, olfactory learning, and decision-making. Key areas include: Olfactory circuits in Drosophila larvae and C. elegans Development of closed-loop imaging systems (e.g., CRASH2p) Multi-neuronal recording in unrestrained animals Integration of learned and innate sensory valences Awards & Recognition NSF CAREER Award (2015) NIH Director's New Innovator Award (2015) Lab & Collaborations His lab integrates engineering and biology, with a focus on creating tools for real-time neural activity analysis. Collaborations likely span physics, neuroscience, and computational biology. The lab homepage provides further details on ongoing projects and publications.